Adam S. Grossman - Mar 6, 2024 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Signature
/s/ Adam S. Grossman, by Brian Lenz as Attorney-in-fact
Stock symbol
ADMA
Transactions as of
Mar 6, 2024
Transactions value $
-$513,798
Form type
4
Date filed
3/8/2024, 09:00 PM
Previous filing
Mar 4, 2024
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Tax liability -$337K -55K -2% $6.12 2.7M Mar 6, 2024 Direct F1, F2, F3
transaction ADMA Common Stock Tax liability -$177K -28.8K -1.06% $6.16 2.67M Mar 7, 2024 Direct F1, F2, F3
holding ADMA Common Stock 1.14M Mar 6, 2024 See Footnote F4
holding ADMA Common Stock 581K Mar 6, 2024 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes, as of the transaction date, (i) 557,728 RSUs granted on February 26, 2024, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 430,272 unvested RSUs granted on March 6, 2023 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 150,000 unvested RSUs granted on March 7, 2022 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting;
F2 (continued from footnote 2) (iv) 226,875 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs") which will vest in eight (8) equal quarterly installments over a period of two years following December 31, 2022, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date; (v) 45,785 unvested RSUs granted on February 25, 2021, which will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, will be settled into common stock upon vesting;
F3 (continued from footnote 3) and (vi) 1,262,567 shares of common stock owned by the reporting person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.
F4 These shares are owned by Areth, LLC ("Areth"). The reporting person is a control person of Areth.
F5 These shares are owned by Hariden, LLC ("Hariden"). The reporting person is the managing member of Hariden.